nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC1—Rosuvastatin—atherosclerosis	0.0421	0.0538	CbGbCtD
Indinavir—SLCO1A2—Rosuvastatin—atherosclerosis	0.0376	0.048	CbGbCtD
Indinavir—SLCO1B1—Rosuvastatin—atherosclerosis	0.0355	0.0453	CbGbCtD
Indinavir—SLCO1B1—Ezetimibe—atherosclerosis	0.0355	0.0453	CbGbCtD
Indinavir—SLCO1A2—Simvastatin—atherosclerosis	0.035	0.0446	CbGbCtD
Indinavir—SLCO1A2—Pravastatin—atherosclerosis	0.0342	0.0437	CbGbCtD
Indinavir—SLCO1A2—Lovastatin—atherosclerosis	0.0342	0.0437	CbGbCtD
Indinavir—SLCO1B1—Simvastatin—atherosclerosis	0.033	0.0421	CbGbCtD
Indinavir—SLCO1B1—Lovastatin—atherosclerosis	0.0323	0.0412	CbGbCtD
Indinavir—SLCO1B1—Pravastatin—atherosclerosis	0.0323	0.0412	CbGbCtD
Indinavir—ABCC2—Ezetimibe—atherosclerosis	0.0312	0.0398	CbGbCtD
Indinavir—ABCC2—Simvastatin—atherosclerosis	0.029	0.037	CbGbCtD
Indinavir—ABCC2—Pravastatin—atherosclerosis	0.0284	0.0362	CbGbCtD
Indinavir—ABCC2—Lovastatin—atherosclerosis	0.0284	0.0362	CbGbCtD
Indinavir—CYP3A7—Simvastatin—atherosclerosis	0.0194	0.0247	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0194	0.0247	CbGbCtD
Indinavir—CYP3A7—Lovastatin—atherosclerosis	0.019	0.0242	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.019	0.0242	CbGbCtD
Indinavir—CYP3A5—Rosuvastatin—atherosclerosis	0.0156	0.0199	CbGbCtD
Indinavir—CYP3A5—Simvastatin—atherosclerosis	0.0145	0.0185	CbGbCtD
Indinavir—CYP3A5—Pravastatin—atherosclerosis	0.0142	0.0181	CbGbCtD
Indinavir—CYP3A5—Lovastatin—atherosclerosis	0.0142	0.0181	CbGbCtD
Indinavir—CYP2C19—Rosuvastatin—atherosclerosis	0.0126	0.0161	CbGbCtD
Indinavir—CYP2C19—Simvastatin—atherosclerosis	0.0117	0.015	CbGbCtD
Indinavir—CYP2C19—Lovastatin—atherosclerosis	0.0115	0.0146	CbGbCtD
Indinavir—CYP2D6—Niacin—atherosclerosis	0.0113	0.0144	CbGbCtD
Indinavir—CYP2C9—Rosuvastatin—atherosclerosis	0.0105	0.0134	CbGbCtD
Indinavir—ABCB1—Ezetimibe—atherosclerosis	0.0102	0.013	CbGbCtD
Indinavir—CYP2C9—Simvastatin—atherosclerosis	0.00974	0.0124	CbGbCtD
Indinavir—CYP2C9—Pravastatin—atherosclerosis	0.00953	0.0122	CbGbCtD
Indinavir—CYP2C9—Lovastatin—atherosclerosis	0.00953	0.0122	CbGbCtD
Indinavir—ABCB1—Simvastatin—atherosclerosis	0.00945	0.0121	CbGbCtD
Indinavir—ABCB1—Lovastatin—atherosclerosis	0.00925	0.0118	CbGbCtD
Indinavir—ABCB1—Pravastatin—atherosclerosis	0.00925	0.0118	CbGbCtD
Indinavir—CYP2D6—Simvastatin—atherosclerosis	0.00891	0.0114	CbGbCtD
Indinavir—CYP2D6—Pravastatin—atherosclerosis	0.00872	0.0111	CbGbCtD
Indinavir—CYP2D6—Lovastatin—atherosclerosis	0.00872	0.0111	CbGbCtD
Indinavir—CYP3A4—Rosuvastatin—atherosclerosis	0.00609	0.00777	CbGbCtD
Indinavir—CYP3A4—Ezetimibe—atherosclerosis	0.00609	0.00777	CbGbCtD
Indinavir—CYP3A4—Simvastatin—atherosclerosis	0.00566	0.00723	CbGbCtD
Indinavir—CYP3A4—Pravastatin—atherosclerosis	0.00554	0.00707	CbGbCtD
Indinavir—CYP3A4—Lovastatin—atherosclerosis	0.00554	0.00707	CbGbCtD
Indinavir—Pharyngitis—Pravastatin—atherosclerosis	0.000321	0.00215	CcSEcCtD
Indinavir—Chills—Simvastatin—atherosclerosis	0.000321	0.00215	CcSEcCtD
Indinavir—Muscle spasms—Lovastatin—atherosclerosis	0.00032	0.00215	CcSEcCtD
Indinavir—Alopecia—Simvastatin—atherosclerosis	0.000316	0.00212	CcSEcCtD
Indinavir—Back pain—Ezetimibe—atherosclerosis	0.000315	0.00212	CcSEcCtD
Indinavir—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000314	0.00211	CcSEcCtD
Indinavir—Muscle spasms—Ezetimibe—atherosclerosis	0.000314	0.0021	CcSEcCtD
Indinavir—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000314	0.0021	CcSEcCtD
Indinavir—Vision blurred—Lovastatin—atherosclerosis	0.000313	0.0021	CcSEcCtD
Indinavir—Tremor—Lovastatin—atherosclerosis	0.000312	0.00209	CcSEcCtD
Indinavir—Ill-defined disorder—Lovastatin—atherosclerosis	0.000309	0.00207	CcSEcCtD
Indinavir—Flatulence—Simvastatin—atherosclerosis	0.000306	0.00206	CcSEcCtD
Indinavir—Erythema multiforme—Pravastatin—atherosclerosis	0.000305	0.00205	CcSEcCtD
Indinavir—Dysgeusia—Simvastatin—atherosclerosis	0.000305	0.00204	CcSEcCtD
Indinavir—Flushing—Niacin—atherosclerosis	0.000304	0.00204	CcSEcCtD
Indinavir—Angioedema—Lovastatin—atherosclerosis	0.000304	0.00204	CcSEcCtD
Indinavir—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000303	0.00203	CcSEcCtD
Indinavir—Anaemia—Ezetimibe—atherosclerosis	0.000301	0.00202	CcSEcCtD
Indinavir—Malaise—Lovastatin—atherosclerosis	0.0003	0.00201	CcSEcCtD
Indinavir—Flushing—Pravastatin—atherosclerosis	0.0003	0.00201	CcSEcCtD
Indinavir—Muscle spasms—Simvastatin—atherosclerosis	0.000299	0.00201	CcSEcCtD
Indinavir—Vertigo—Lovastatin—atherosclerosis	0.000299	0.00201	CcSEcCtD
Indinavir—Angioedema—Ezetimibe—atherosclerosis	0.000298	0.002	CcSEcCtD
Indinavir—Chills—Niacin—atherosclerosis	0.000294	0.00198	CcSEcCtD
Indinavir—Malaise—Ezetimibe—atherosclerosis	0.000294	0.00197	CcSEcCtD
Indinavir—Vision blurred—Simvastatin—atherosclerosis	0.000293	0.00197	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000292	0.00196	CcSEcCtD
Indinavir—Tremor—Simvastatin—atherosclerosis	0.000291	0.00196	CcSEcCtD
Indinavir—Alopecia—Niacin—atherosclerosis	0.00029	0.00195	CcSEcCtD
Indinavir—Chills—Pravastatin—atherosclerosis	0.00029	0.00195	CcSEcCtD
Indinavir—Insomnia—Rosuvastatin—atherosclerosis	0.00029	0.00194	CcSEcCtD
Indinavir—Ill-defined disorder—Simvastatin—atherosclerosis	0.000289	0.00194	CcSEcCtD
Indinavir—Palpitations—Ezetimibe—atherosclerosis	0.000288	0.00193	CcSEcCtD
Indinavir—Paraesthesia—Rosuvastatin—atherosclerosis	0.000288	0.00193	CcSEcCtD
Indinavir—Anaemia—Simvastatin—atherosclerosis	0.000287	0.00193	CcSEcCtD
Indinavir—Malnutrition—Niacin—atherosclerosis	0.000286	0.00192	CcSEcCtD
Indinavir—Alopecia—Pravastatin—atherosclerosis	0.000285	0.00192	CcSEcCtD
Indinavir—Cough—Ezetimibe—atherosclerosis	0.000285	0.00191	CcSEcCtD
Indinavir—Angioedema—Simvastatin—atherosclerosis	0.000284	0.00191	CcSEcCtD
Indinavir—Chest pain—Lovastatin—atherosclerosis	0.000283	0.0019	CcSEcCtD
Indinavir—Myalgia—Lovastatin—atherosclerosis	0.000283	0.0019	CcSEcCtD
Indinavir—Arthralgia—Lovastatin—atherosclerosis	0.000283	0.0019	CcSEcCtD
Indinavir—Anxiety—Lovastatin—atherosclerosis	0.000282	0.00189	CcSEcCtD
Indinavir—Dyspepsia—Rosuvastatin—atherosclerosis	0.000282	0.00189	CcSEcCtD
Indinavir—Flatulence—Niacin—atherosclerosis	0.000281	0.00189	CcSEcCtD
Indinavir—Malaise—Simvastatin—atherosclerosis	0.00028	0.00188	CcSEcCtD
Indinavir—Tension—Niacin—atherosclerosis	0.00028	0.00188	CcSEcCtD
Indinavir—Discomfort—Lovastatin—atherosclerosis	0.00028	0.00188	CcSEcCtD
Indinavir—Vertigo—Simvastatin—atherosclerosis	0.000279	0.00188	CcSEcCtD
Indinavir—Chest pain—Ezetimibe—atherosclerosis	0.000278	0.00186	CcSEcCtD
Indinavir—Arthralgia—Ezetimibe—atherosclerosis	0.000278	0.00186	CcSEcCtD
Indinavir—Myalgia—Ezetimibe—atherosclerosis	0.000278	0.00186	CcSEcCtD
Indinavir—Nervousness—Niacin—atherosclerosis	0.000277	0.00186	CcSEcCtD
Indinavir—Flatulence—Pravastatin—atherosclerosis	0.000277	0.00186	CcSEcCtD
Indinavir—Dry mouth—Lovastatin—atherosclerosis	0.000277	0.00186	CcSEcCtD
Indinavir—Tension—Pravastatin—atherosclerosis	0.000276	0.00185	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000276	0.00185	CcSEcCtD
Indinavir—Dysgeusia—Pravastatin—atherosclerosis	0.000275	0.00185	CcSEcCtD
Indinavir—Muscle spasms—Niacin—atherosclerosis	0.000275	0.00184	CcSEcCtD
Indinavir—Discomfort—Ezetimibe—atherosclerosis	0.000274	0.00184	CcSEcCtD
Indinavir—Constipation—Rosuvastatin—atherosclerosis	0.000274	0.00184	CcSEcCtD
Indinavir—Pain—Rosuvastatin—atherosclerosis	0.000274	0.00184	CcSEcCtD
Indinavir—Nervousness—Pravastatin—atherosclerosis	0.000273	0.00183	CcSEcCtD
Indinavir—Dry mouth—Ezetimibe—atherosclerosis	0.000272	0.00182	CcSEcCtD
Indinavir—Anaphylactic shock—Lovastatin—atherosclerosis	0.000271	0.00182	CcSEcCtD
Indinavir—Muscle spasms—Pravastatin—atherosclerosis	0.00027	0.00181	CcSEcCtD
Indinavir—Vision blurred—Niacin—atherosclerosis	0.000269	0.00181	CcSEcCtD
Indinavir—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000266	0.00179	CcSEcCtD
Indinavir—Thrombocytopenia—Lovastatin—atherosclerosis	0.000266	0.00178	CcSEcCtD
Indinavir—Vision blurred—Pravastatin—atherosclerosis	0.000265	0.00178	CcSEcCtD
Indinavir—Myalgia—Simvastatin—atherosclerosis	0.000265	0.00178	CcSEcCtD
Indinavir—Chest pain—Simvastatin—atherosclerosis	0.000265	0.00178	CcSEcCtD
Indinavir—Arthralgia—Simvastatin—atherosclerosis	0.000265	0.00178	CcSEcCtD
Indinavir—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000264	0.00177	CcSEcCtD
Indinavir—Anxiety—Simvastatin—atherosclerosis	0.000264	0.00177	CcSEcCtD
Indinavir—Tremor—Pravastatin—atherosclerosis	0.000263	0.00177	CcSEcCtD
Indinavir—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000262	0.00176	CcSEcCtD
Indinavir—Discomfort—Simvastatin—atherosclerosis	0.000262	0.00176	CcSEcCtD
Indinavir—Nervous system disorder—Ezetimibe—atherosclerosis	0.000261	0.00175	CcSEcCtD
Indinavir—Angioedema—Niacin—atherosclerosis	0.000261	0.00175	CcSEcCtD
Indinavir—Ill-defined disorder—Pravastatin—atherosclerosis	0.000261	0.00175	CcSEcCtD
Indinavir—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000261	0.00175	CcSEcCtD
Indinavir—Anaemia—Pravastatin—atherosclerosis	0.00026	0.00174	CcSEcCtD
Indinavir—Anorexia—Lovastatin—atherosclerosis	0.000259	0.00174	CcSEcCtD
Indinavir—Skin disorder—Ezetimibe—atherosclerosis	0.000259	0.00174	CcSEcCtD
Indinavir—Angioedema—Pravastatin—atherosclerosis	0.000257	0.00172	CcSEcCtD
Indinavir—Vertigo—Niacin—atherosclerosis	0.000257	0.00172	CcSEcCtD
Indinavir—Syncope—Niacin—atherosclerosis	0.000256	0.00172	CcSEcCtD
Indinavir—Urticaria—Rosuvastatin—atherosclerosis	0.000254	0.00171	CcSEcCtD
Indinavir—Oedema—Simvastatin—atherosclerosis	0.000254	0.0017	CcSEcCtD
Indinavir—Anaphylactic shock—Simvastatin—atherosclerosis	0.000254	0.0017	CcSEcCtD
Indinavir—Malaise—Pravastatin—atherosclerosis	0.000254	0.0017	CcSEcCtD
Indinavir—Abdominal pain—Rosuvastatin—atherosclerosis	0.000253	0.0017	CcSEcCtD
Indinavir—Vertigo—Pravastatin—atherosclerosis	0.000253	0.0017	CcSEcCtD
Indinavir—Palpitations—Niacin—atherosclerosis	0.000252	0.00169	CcSEcCtD
Indinavir—Loss of consciousness—Niacin—atherosclerosis	0.000251	0.00168	CcSEcCtD
Indinavir—Cough—Niacin—atherosclerosis	0.000249	0.00167	CcSEcCtD
Indinavir—Thrombocytopenia—Simvastatin—atherosclerosis	0.000249	0.00167	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000247	0.00166	CcSEcCtD
Indinavir—Insomnia—Lovastatin—atherosclerosis	0.000245	0.00165	CcSEcCtD
Indinavir—Cough—Pravastatin—atherosclerosis	0.000245	0.00165	CcSEcCtD
Indinavir—Paraesthesia—Lovastatin—atherosclerosis	0.000244	0.00164	CcSEcCtD
Indinavir—Arthralgia—Niacin—atherosclerosis	0.000243	0.00163	CcSEcCtD
Indinavir—Myalgia—Niacin—atherosclerosis	0.000243	0.00163	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000242	0.00163	CcSEcCtD
Indinavir—Anorexia—Simvastatin—atherosclerosis	0.000242	0.00162	CcSEcCtD
Indinavir—Dyspnoea—Lovastatin—atherosclerosis	0.000242	0.00162	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000241	0.00162	CcSEcCtD
Indinavir—Insomnia—Ezetimibe—atherosclerosis	0.000241	0.00162	CcSEcCtD
Indinavir—Arthralgia—Pravastatin—atherosclerosis	0.000239	0.00161	CcSEcCtD
Indinavir—Myalgia—Pravastatin—atherosclerosis	0.000239	0.00161	CcSEcCtD
Indinavir—Chest pain—Pravastatin—atherosclerosis	0.000239	0.00161	CcSEcCtD
Indinavir—Paraesthesia—Ezetimibe—atherosclerosis	0.000239	0.0016	CcSEcCtD
Indinavir—Dyspepsia—Lovastatin—atherosclerosis	0.000239	0.0016	CcSEcCtD
Indinavir—Anxiety—Pravastatin—atherosclerosis	0.000239	0.0016	CcSEcCtD
Indinavir—Dry mouth—Niacin—atherosclerosis	0.000238	0.0016	CcSEcCtD
Indinavir—Dyspnoea—Ezetimibe—atherosclerosis	0.000237	0.00159	CcSEcCtD
Indinavir—Discomfort—Pravastatin—atherosclerosis	0.000237	0.00159	CcSEcCtD
Indinavir—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000236	0.00158	CcSEcCtD
Indinavir—Decreased appetite—Lovastatin—atherosclerosis	0.000236	0.00158	CcSEcCtD
Indinavir—Dyspepsia—Ezetimibe—atherosclerosis	0.000234	0.00157	CcSEcCtD
Indinavir—Fatigue—Lovastatin—atherosclerosis	0.000234	0.00157	CcSEcCtD
Indinavir—Oedema—Niacin—atherosclerosis	0.000233	0.00156	CcSEcCtD
Indinavir—Anaphylactic shock—Niacin—atherosclerosis	0.000233	0.00156	CcSEcCtD
Indinavir—Constipation—Lovastatin—atherosclerosis	0.000232	0.00156	CcSEcCtD
Indinavir—Pain—Lovastatin—atherosclerosis	0.000232	0.00156	CcSEcCtD
Indinavir—Decreased appetite—Ezetimibe—atherosclerosis	0.000231	0.00155	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000231	0.00155	CcSEcCtD
Indinavir—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00023	0.00154	CcSEcCtD
Indinavir—Asthenia—Rosuvastatin—atherosclerosis	0.00023	0.00154	CcSEcCtD
Indinavir—Insomnia—Simvastatin—atherosclerosis	0.00023	0.00154	CcSEcCtD
Indinavir—Oedema—Pravastatin—atherosclerosis	0.000229	0.00154	CcSEcCtD
Indinavir—Anaphylactic shock—Pravastatin—atherosclerosis	0.000229	0.00154	CcSEcCtD
Indinavir—Fatigue—Ezetimibe—atherosclerosis	0.000229	0.00154	CcSEcCtD
Indinavir—Shock—Niacin—atherosclerosis	0.000229	0.00154	CcSEcCtD
Indinavir—Paraesthesia—Simvastatin—atherosclerosis	0.000228	0.00153	CcSEcCtD
Indinavir—Pain—Ezetimibe—atherosclerosis	0.000228	0.00153	CcSEcCtD
Indinavir—Constipation—Ezetimibe—atherosclerosis	0.000228	0.00153	CcSEcCtD
Indinavir—Pruritus—Rosuvastatin—atherosclerosis	0.000227	0.00152	CcSEcCtD
Indinavir—Skin disorder—Niacin—atherosclerosis	0.000226	0.00152	CcSEcCtD
Indinavir—Dyspnoea—Simvastatin—atherosclerosis	0.000226	0.00152	CcSEcCtD
Indinavir—Hyperhidrosis—Niacin—atherosclerosis	0.000225	0.00151	CcSEcCtD
Indinavir—Thrombocytopenia—Pravastatin—atherosclerosis	0.000225	0.00151	CcSEcCtD
Indinavir—Feeling abnormal—Lovastatin—atherosclerosis	0.000224	0.0015	CcSEcCtD
Indinavir—Dyspepsia—Simvastatin—atherosclerosis	0.000223	0.0015	CcSEcCtD
Indinavir—Anorexia—Niacin—atherosclerosis	0.000222	0.00149	CcSEcCtD
Indinavir—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000222	0.00149	CcSEcCtD
Indinavir—Hyperhidrosis—Pravastatin—atherosclerosis	0.000222	0.00149	CcSEcCtD
Indinavir—Decreased appetite—Simvastatin—atherosclerosis	0.000221	0.00148	CcSEcCtD
Indinavir—Feeling abnormal—Ezetimibe—atherosclerosis	0.000219	0.00147	CcSEcCtD
Indinavir—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000219	0.00147	CcSEcCtD
Indinavir—Diarrhoea—Rosuvastatin—atherosclerosis	0.000219	0.00147	CcSEcCtD
Indinavir—Fatigue—Simvastatin—atherosclerosis	0.000219	0.00147	CcSEcCtD
Indinavir—Anorexia—Pravastatin—atherosclerosis	0.000219	0.00147	CcSEcCtD
Indinavir—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000218	0.00146	CcSEcCtD
Indinavir—Pain—Simvastatin—atherosclerosis	0.000217	0.00146	CcSEcCtD
Indinavir—Constipation—Simvastatin—atherosclerosis	0.000217	0.00146	CcSEcCtD
Indinavir—Urticaria—Lovastatin—atherosclerosis	0.000216	0.00145	CcSEcCtD
Indinavir—Body temperature increased—Lovastatin—atherosclerosis	0.000215	0.00144	CcSEcCtD
Indinavir—Abdominal pain—Lovastatin—atherosclerosis	0.000215	0.00144	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000212	0.00143	CcSEcCtD
Indinavir—Dizziness—Rosuvastatin—atherosclerosis	0.000212	0.00142	CcSEcCtD
Indinavir—Urticaria—Ezetimibe—atherosclerosis	0.000211	0.00142	CcSEcCtD
Indinavir—Insomnia—Niacin—atherosclerosis	0.000211	0.00141	CcSEcCtD
Indinavir—Body temperature increased—Ezetimibe—atherosclerosis	0.00021	0.00141	CcSEcCtD
Indinavir—Abdominal pain—Ezetimibe—atherosclerosis	0.00021	0.00141	CcSEcCtD
Indinavir—Paraesthesia—Niacin—atherosclerosis	0.000209	0.0014	CcSEcCtD
Indinavir—Feeling abnormal—Simvastatin—atherosclerosis	0.000209	0.0014	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000209	0.0014	CcSEcCtD
Indinavir—Dyspnoea—Niacin—atherosclerosis	0.000208	0.00139	CcSEcCtD
Indinavir—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000208	0.00139	CcSEcCtD
Indinavir—Insomnia—Pravastatin—atherosclerosis	0.000208	0.00139	CcSEcCtD
Indinavir—Somnolence—Niacin—atherosclerosis	0.000207	0.00139	CcSEcCtD
Indinavir—Paraesthesia—Pravastatin—atherosclerosis	0.000206	0.00138	CcSEcCtD
Indinavir—Dyspepsia—Niacin—atherosclerosis	0.000205	0.00138	CcSEcCtD
Indinavir—Dyspnoea—Pravastatin—atherosclerosis	0.000205	0.00137	CcSEcCtD
Indinavir—Decreased appetite—Niacin—atherosclerosis	0.000203	0.00136	CcSEcCtD
Indinavir—Dyspepsia—Pravastatin—atherosclerosis	0.000202	0.00136	CcSEcCtD
Indinavir—Rash—Rosuvastatin—atherosclerosis	0.000202	0.00136	CcSEcCtD
Indinavir—Dermatitis—Rosuvastatin—atherosclerosis	0.000202	0.00135	CcSEcCtD
Indinavir—Urticaria—Simvastatin—atherosclerosis	0.000202	0.00135	CcSEcCtD
Indinavir—Gastrointestinal disorder—Niacin—atherosclerosis	0.000201	0.00135	CcSEcCtD
Indinavir—Abdominal pain—Simvastatin—atherosclerosis	0.000201	0.00135	CcSEcCtD
Indinavir—Body temperature increased—Simvastatin—atherosclerosis	0.000201	0.00135	CcSEcCtD
Indinavir—Headache—Rosuvastatin—atherosclerosis	0.000201	0.00135	CcSEcCtD
Indinavir—Hypersensitivity—Lovastatin—atherosclerosis	0.0002	0.00134	CcSEcCtD
Indinavir—Decreased appetite—Pravastatin—atherosclerosis	0.000199	0.00134	CcSEcCtD
Indinavir—Pain—Niacin—atherosclerosis	0.000199	0.00134	CcSEcCtD
Indinavir—Fatigue—Pravastatin—atherosclerosis	0.000198	0.00133	CcSEcCtD
Indinavir—Pain—Pravastatin—atherosclerosis	0.000196	0.00132	CcSEcCtD
Indinavir—Constipation—Pravastatin—atherosclerosis	0.000196	0.00132	CcSEcCtD
Indinavir—Hypersensitivity—Ezetimibe—atherosclerosis	0.000196	0.00132	CcSEcCtD
Indinavir—Asthenia—Lovastatin—atherosclerosis	0.000195	0.00131	CcSEcCtD
Indinavir—Pruritus—Lovastatin—atherosclerosis	0.000192	0.00129	CcSEcCtD
Indinavir—Asthenia—Ezetimibe—atherosclerosis	0.000191	0.00128	CcSEcCtD
Indinavir—Gastrointestinal pain—Niacin—atherosclerosis	0.000191	0.00128	CcSEcCtD
Indinavir—Nausea—Rosuvastatin—atherosclerosis	0.00019	0.00128	CcSEcCtD
Indinavir—Feeling abnormal—Pravastatin—atherosclerosis	0.000189	0.00127	CcSEcCtD
Indinavir—Pruritus—Ezetimibe—atherosclerosis	0.000188	0.00126	CcSEcCtD
Indinavir—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000188	0.00126	CcSEcCtD
Indinavir—Hypersensitivity—Simvastatin—atherosclerosis	0.000187	0.00126	CcSEcCtD
Indinavir—Diarrhoea—Lovastatin—atherosclerosis	0.000186	0.00125	CcSEcCtD
Indinavir—Urticaria—Niacin—atherosclerosis	0.000185	0.00124	CcSEcCtD
Indinavir—Abdominal pain—Niacin—atherosclerosis	0.000184	0.00124	CcSEcCtD
Indinavir—Body temperature increased—Niacin—atherosclerosis	0.000184	0.00124	CcSEcCtD
Indinavir—Urticaria—Pravastatin—atherosclerosis	0.000182	0.00122	CcSEcCtD
Indinavir—Asthenia—Simvastatin—atherosclerosis	0.000182	0.00122	CcSEcCtD
Indinavir—Diarrhoea—Ezetimibe—atherosclerosis	0.000182	0.00122	CcSEcCtD
Indinavir—Abdominal pain—Pravastatin—atherosclerosis	0.000181	0.00122	CcSEcCtD
Indinavir—Body temperature increased—Pravastatin—atherosclerosis	0.000181	0.00122	CcSEcCtD
Indinavir—Pruritus—Simvastatin—atherosclerosis	0.00018	0.00121	CcSEcCtD
Indinavir—Dizziness—Lovastatin—atherosclerosis	0.000179	0.0012	CcSEcCtD
Indinavir—Dizziness—Ezetimibe—atherosclerosis	0.000176	0.00118	CcSEcCtD
Indinavir—Diarrhoea—Simvastatin—atherosclerosis	0.000174	0.00117	CcSEcCtD
Indinavir—Vomiting—Lovastatin—atherosclerosis	0.000173	0.00116	CcSEcCtD
Indinavir—Hypersensitivity—Niacin—atherosclerosis	0.000172	0.00115	CcSEcCtD
Indinavir—Rash—Lovastatin—atherosclerosis	0.000171	0.00115	CcSEcCtD
Indinavir—Dermatitis—Lovastatin—atherosclerosis	0.000171	0.00115	CcSEcCtD
Indinavir—Headache—Lovastatin—atherosclerosis	0.00017	0.00114	CcSEcCtD
Indinavir—Vomiting—Ezetimibe—atherosclerosis	0.000169	0.00114	CcSEcCtD
Indinavir—Hypersensitivity—Pravastatin—atherosclerosis	0.000169	0.00113	CcSEcCtD
Indinavir—Dizziness—Simvastatin—atherosclerosis	0.000168	0.00113	CcSEcCtD
Indinavir—Rash—Ezetimibe—atherosclerosis	0.000168	0.00113	CcSEcCtD
Indinavir—Dermatitis—Ezetimibe—atherosclerosis	0.000168	0.00113	CcSEcCtD
Indinavir—Asthenia—Niacin—atherosclerosis	0.000167	0.00112	CcSEcCtD
Indinavir—Headache—Ezetimibe—atherosclerosis	0.000167	0.00112	CcSEcCtD
Indinavir—Pruritus—Niacin—atherosclerosis	0.000165	0.00111	CcSEcCtD
Indinavir—Asthenia—Pravastatin—atherosclerosis	0.000165	0.00111	CcSEcCtD
Indinavir—Pruritus—Pravastatin—atherosclerosis	0.000162	0.00109	CcSEcCtD
Indinavir—Vomiting—Simvastatin—atherosclerosis	0.000161	0.00108	CcSEcCtD
Indinavir—Nausea—Lovastatin—atherosclerosis	0.000161	0.00108	CcSEcCtD
Indinavir—Rash—Simvastatin—atherosclerosis	0.00016	0.00107	CcSEcCtD
Indinavir—Dermatitis—Simvastatin—atherosclerosis	0.00016	0.00107	CcSEcCtD
Indinavir—Diarrhoea—Niacin—atherosclerosis	0.000159	0.00107	CcSEcCtD
Indinavir—Headache—Simvastatin—atherosclerosis	0.000159	0.00107	CcSEcCtD
Indinavir—Nausea—Ezetimibe—atherosclerosis	0.000158	0.00106	CcSEcCtD
Indinavir—Diarrhoea—Pravastatin—atherosclerosis	0.000157	0.00105	CcSEcCtD
Indinavir—Dizziness—Niacin—atherosclerosis	0.000154	0.00103	CcSEcCtD
Indinavir—Dizziness—Pravastatin—atherosclerosis	0.000152	0.00102	CcSEcCtD
Indinavir—Nausea—Simvastatin—atherosclerosis	0.000151	0.00101	CcSEcCtD
Indinavir—Vomiting—Niacin—atherosclerosis	0.000148	0.000995	CcSEcCtD
Indinavir—Rash—Niacin—atherosclerosis	0.000147	0.000986	CcSEcCtD
Indinavir—Dermatitis—Niacin—atherosclerosis	0.000147	0.000986	CcSEcCtD
Indinavir—Headache—Niacin—atherosclerosis	0.000146	0.00098	CcSEcCtD
Indinavir—Vomiting—Pravastatin—atherosclerosis	0.000146	0.000979	CcSEcCtD
Indinavir—Rash—Pravastatin—atherosclerosis	0.000145	0.000971	CcSEcCtD
Indinavir—Dermatitis—Pravastatin—atherosclerosis	0.000145	0.00097	CcSEcCtD
Indinavir—Headache—Pravastatin—atherosclerosis	0.000144	0.000965	CcSEcCtD
Indinavir—Nausea—Niacin—atherosclerosis	0.000138	0.000929	CcSEcCtD
Indinavir—Nausea—Pravastatin—atherosclerosis	0.000136	0.000915	CcSEcCtD
Indinavir—ABCC1—Metabolism—CAV1—atherosclerosis	8.77e-06	0.00013	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.75e-06	0.00013	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CD36—atherosclerosis	8.75e-06	0.00013	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—APOA1—atherosclerosis	8.75e-06	0.00013	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	8.74e-06	0.00013	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GSTM1—atherosclerosis	8.73e-06	0.00013	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.73e-06	0.00013	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALOX5—atherosclerosis	8.7e-06	0.000129	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALOX5—atherosclerosis	8.62e-06	0.000128	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AGT—atherosclerosis	8.58e-06	0.000128	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—LPL—atherosclerosis	8.57e-06	0.000127	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PPARG—atherosclerosis	8.56e-06	0.000127	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NAMPT—atherosclerosis	8.48e-06	0.000126	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ABCA1—atherosclerosis	8.48e-06	0.000126	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	8.43e-06	0.000125	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—LIPC—atherosclerosis	8.43e-06	0.000125	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCG1—atherosclerosis	8.42e-06	0.000125	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—APOE—atherosclerosis	8.41e-06	0.000125	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—INS—atherosclerosis	8.4e-06	0.000125	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOC3—atherosclerosis	8.38e-06	0.000125	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—GPX1—atherosclerosis	8.36e-06	0.000124	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CAV1—atherosclerosis	8.33e-06	0.000124	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—LDLR—atherosclerosis	8.33e-06	0.000124	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—APOA1—atherosclerosis	8.31e-06	0.000124	CbGpPWpGaD
Indinavir—ABCC1—Disease—SERPINE1—atherosclerosis	8.29e-06	0.000123	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—MTHFR—atherosclerosis	8.29e-06	0.000123	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NAMPT—atherosclerosis	8.28e-06	0.000123	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—LIPC—atherosclerosis	8.23e-06	0.000122	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOC3—atherosclerosis	8.18e-06	0.000122	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CD36—atherosclerosis	8.14e-06	0.000121	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CETP—atherosclerosis	8.13e-06	0.000121	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARA—atherosclerosis	8.13e-06	0.000121	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—LDLR—atherosclerosis	8.13e-06	0.000121	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CG—atherosclerosis	7.98e-06	0.000119	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.97e-06	0.000118	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CETP—atherosclerosis	7.94e-06	0.000118	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—FABP4—atherosclerosis	7.92e-06	0.000118	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LCAT—atherosclerosis	7.92e-06	0.000118	CbGpPWpGaD
Indinavir—ABCC1—Disease—NOS3—atherosclerosis	7.91e-06	0.000118	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AGT—atherosclerosis	7.88e-06	0.000117	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NAMPT—atherosclerosis	7.8e-06	0.000116	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.79e-06	0.000116	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SCARB1—atherosclerosis	7.79e-06	0.000116	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOA4—atherosclerosis	7.77e-06	0.000115	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—LIPC—atherosclerosis	7.75e-06	0.000115	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NAMPT—atherosclerosis	7.74e-06	0.000115	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—APOE—atherosclerosis	7.72e-06	0.000115	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—MTHFR—atherosclerosis	7.71e-06	0.000115	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PPARG—atherosclerosis	7.71e-06	0.000115	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOC3—atherosclerosis	7.71e-06	0.000115	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—ALB—atherosclerosis	7.7e-06	0.000114	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.69e-06	0.000114	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—LIPC—atherosclerosis	7.69e-06	0.000114	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—LDLR—atherosclerosis	7.66e-06	0.000114	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CAV1—atherosclerosis	7.65e-06	0.000114	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOC3—atherosclerosis	7.64e-06	0.000114	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP7A1—atherosclerosis	7.63e-06	0.000113	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—APOA1—atherosclerosis	7.63e-06	0.000113	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SCARB1—atherosclerosis	7.6e-06	0.000113	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—LDLR—atherosclerosis	7.59e-06	0.000113	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	7.59e-06	0.000113	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	7.58e-06	0.000113	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARA—atherosclerosis	7.57e-06	0.000112	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—INS—atherosclerosis	7.56e-06	0.000112	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CETP—atherosclerosis	7.48e-06	0.000111	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CETP—atherosclerosis	7.42e-06	0.00011	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—NOS3—atherosclerosis	7.37e-06	0.000109	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HMGCR—atherosclerosis	7.36e-06	0.000109	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AGT—atherosclerosis	7.33e-06	0.000109	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PPARG—atherosclerosis	7.32e-06	0.000109	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—HMOX1—atherosclerosis	7.28e-06	0.000108	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTGS2—atherosclerosis	7.24e-06	0.000108	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—INS—atherosclerosis	7.18e-06	0.000107	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APOE—atherosclerosis	7.18e-06	0.000107	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HMGCR—atherosclerosis	7.18e-06	0.000107	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.16e-06	0.000106	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CAV1—atherosclerosis	7.12e-06	0.000106	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.1e-06	0.000106	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—APOA1—atherosclerosis	7.1e-06	0.000106	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.06e-06	0.000105	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	7.04e-06	0.000105	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOB—atherosclerosis	6.97e-06	0.000104	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CG—atherosclerosis	6.96e-06	0.000104	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—ALB—atherosclerosis	6.93e-06	0.000103	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.92e-06	0.000103	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GSTM1—atherosclerosis	6.78e-06	0.000101	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HMGCR—atherosclerosis	6.77e-06	0.000101	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTGS2—atherosclerosis	6.74e-06	0.0001	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PPARG—atherosclerosis	6.72e-06	9.99e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HMGCR—atherosclerosis	6.71e-06	9.97e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.69e-06	9.94e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOA2—atherosclerosis	6.69e-06	9.94e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.69e-06	9.94e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.69e-06	9.94e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—LPL—atherosclerosis	6.65e-06	9.89e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.63e-06	9.86e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—NOS3—atherosclerosis	6.63e-06	9.85e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.61e-06	9.82e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—INS—atherosclerosis	6.59e-06	9.8e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—ALB—atherosclerosis	6.59e-06	9.79e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ABCA1—atherosclerosis	6.56e-06	9.74e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—GPX1—atherosclerosis	6.49e-06	9.65e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CG—atherosclerosis	6.48e-06	9.63e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ABCA1—atherosclerosis	6.4e-06	9.51e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LPA—atherosclerosis	6.38e-06	9.48e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CD36—atherosclerosis	6.32e-06	9.4e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—NOS3—atherosclerosis	6.3e-06	9.36e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PPARG—atherosclerosis	6.26e-06	9.3e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—BGN—atherosclerosis	6.18e-06	9.19e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—INS—atherosclerosis	6.13e-06	9.12e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOA5—atherosclerosis	6.12e-06	9.09e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTGS2—atherosclerosis	6.06e-06	9.01e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.05e-06	8.99e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—ALB—atherosclerosis	6.04e-06	8.98e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.03e-06	8.96e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—MTHFR—atherosclerosis	5.99e-06	8.9e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.98e-06	8.88e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.89e-06	8.75e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARA—atherosclerosis	5.88e-06	8.74e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—NOS3—atherosclerosis	5.78e-06	8.59e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTGS2—atherosclerosis	5.76e-06	8.56e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AGT—atherosclerosis	5.69e-06	8.46e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.69e-06	8.45e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—STAT3—atherosclerosis	5.65e-06	8.39e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—HMOX1—atherosclerosis	5.63e-06	8.36e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—ALB—atherosclerosis	5.62e-06	8.36e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOE—atherosclerosis	5.58e-06	8.29e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CAV1—atherosclerosis	5.53e-06	8.21e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—APOA1—atherosclerosis	5.51e-06	8.2e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—HMOX1—atherosclerosis	5.49e-06	8.16e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—MAPK3—atherosclerosis	5.39e-06	8.02e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOB—atherosclerosis	5.39e-06	8.01e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—NOS3—atherosclerosis	5.38e-06	8e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTGS2—atherosclerosis	5.29e-06	7.86e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOB—atherosclerosis	5.26e-06	7.82e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GSTM1—atherosclerosis	5.24e-06	7.79e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—TGFB1—atherosclerosis	5.23e-06	7.78e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.17e-06	7.69e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—LPL—atherosclerosis	5.14e-06	7.65e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.13e-06	7.62e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GSTM1—atherosclerosis	5.12e-06	7.6e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.1e-06	7.58e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LIPC—atherosclerosis	5.07e-06	7.53e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOC3—atherosclerosis	5.04e-06	7.49e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CG—atherosclerosis	5.03e-06	7.48e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—LPL—atherosclerosis	5.02e-06	7.46e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—GPX1—atherosclerosis	5.02e-06	7.46e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LDLR—atherosclerosis	5.01e-06	7.44e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOB—atherosclerosis	4.96e-06	7.37e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTGS2—atherosclerosis	4.92e-06	7.31e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOB—atherosclerosis	4.91e-06	7.3e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—GPX1—atherosclerosis	4.9e-06	7.28e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CETP—atherosclerosis	4.89e-06	7.27e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CD36—atherosclerosis	4.89e-06	7.27e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PPARG—atherosclerosis	4.86e-06	7.22e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.82e-06	7.16e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.78e-06	7.1e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CD36—atherosclerosis	4.77e-06	7.09e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—INS—atherosclerosis	4.77e-06	7.08e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—LPL—atherosclerosis	4.73e-06	7.03e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—LPL—atherosclerosis	4.69e-06	6.97e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.68e-06	6.96e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—MTHFR—atherosclerosis	4.63e-06	6.88e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—GPX1—atherosclerosis	4.62e-06	6.86e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—GPX1—atherosclerosis	4.58e-06	6.8e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARA—atherosclerosis	4.54e-06	6.75e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—MTHFR—atherosclerosis	4.52e-06	6.72e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CD36—atherosclerosis	4.5e-06	6.68e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CD36—atherosclerosis	4.46e-06	6.62e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARA—atherosclerosis	4.44e-06	6.59e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.42e-06	6.57e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AGT—atherosclerosis	4.4e-06	6.54e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—ALB—atherosclerosis	4.37e-06	6.49e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOE—atherosclerosis	4.31e-06	6.41e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AGT—atherosclerosis	4.3e-06	6.38e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CAV1—atherosclerosis	4.27e-06	6.35e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—APOA1—atherosclerosis	4.26e-06	6.34e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.26e-06	6.33e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.22e-06	6.28e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOE—atherosclerosis	4.21e-06	6.26e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARA—atherosclerosis	4.18e-06	6.21e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NOS3—atherosclerosis	4.18e-06	6.21e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CAV1—atherosclerosis	4.17e-06	6.2e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—APOA1—atherosclerosis	4.16e-06	6.18e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARA—atherosclerosis	4.14e-06	6.16e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AGT—atherosclerosis	4.05e-06	6.02e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AGT—atherosclerosis	4.01e-06	5.96e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOE—atherosclerosis	3.97e-06	5.89e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—IL6—atherosclerosis	3.94e-06	5.86e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.94e-06	5.86e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOE—atherosclerosis	3.93e-06	5.84e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CAV1—atherosclerosis	3.93e-06	5.84e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—APOA1—atherosclerosis	3.92e-06	5.83e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CAV1—atherosclerosis	3.9e-06	5.79e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CG—atherosclerosis	3.89e-06	5.78e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—APOA1—atherosclerosis	3.89e-06	5.78e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTGS2—atherosclerosis	3.82e-06	5.68e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.8e-06	5.65e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PPARG—atherosclerosis	3.76e-06	5.58e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—INS—atherosclerosis	3.68e-06	5.48e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PPARG—atherosclerosis	3.67e-06	5.45e-05	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—atherosclerosis	3.64e-06	5.41e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—INS—atherosclerosis	3.6e-06	5.34e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.58e-06	5.32e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.55e-06	5.27e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PPARG—atherosclerosis	3.45e-06	5.13e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PPARG—atherosclerosis	3.42e-06	5.09e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—INS—atherosclerosis	3.39e-06	5.04e-05	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—atherosclerosis	3.39e-06	5.03e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.38e-06	5.03e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—ALB—atherosclerosis	3.38e-06	5.02e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—INS—atherosclerosis	3.36e-06	4.99e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—ALB—atherosclerosis	3.3e-06	4.9e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOB—atherosclerosis	3.24e-06	4.82e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NOS3—atherosclerosis	3.23e-06	4.8e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NOS3—atherosclerosis	3.15e-06	4.69e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.15e-06	4.68e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—ALB—atherosclerosis	3.11e-06	4.62e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—LPL—atherosclerosis	3.09e-06	4.6e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—ALB—atherosclerosis	3.08e-06	4.58e-05	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—atherosclerosis	3.05e-06	4.53e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—GPX1—atherosclerosis	3.02e-06	4.49e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NOS3—atherosclerosis	2.97e-06	4.42e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTGS2—atherosclerosis	2.95e-06	4.39e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NOS3—atherosclerosis	2.95e-06	4.38e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CD36—atherosclerosis	2.94e-06	4.37e-05	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—atherosclerosis	2.9e-06	4.3e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTGS2—atherosclerosis	2.88e-06	4.29e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.79e-06	4.14e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARA—atherosclerosis	2.73e-06	4.06e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.72e-06	4.04e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.69e-06	4e-05	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—atherosclerosis	2.66e-06	3.95e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AGT—atherosclerosis	2.65e-06	3.93e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOE—atherosclerosis	2.59e-06	3.85e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CAV1—atherosclerosis	2.57e-06	3.82e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—APOA1—atherosclerosis	2.56e-06	3.81e-05	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—atherosclerosis	2.47e-06	3.68e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.34e-06	3.48e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PPARG—atherosclerosis	2.26e-06	3.36e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—INS—atherosclerosis	2.22e-06	3.29e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—ALB—atherosclerosis	2.03e-06	3.02e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NOS3—atherosclerosis	1.94e-06	2.89e-05	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—atherosclerosis	1.92e-06	2.85e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.78e-06	2.64e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—atherosclerosis	1.49e-06	2.21e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—atherosclerosis	1.45e-06	2.15e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—atherosclerosis	1.37e-06	2.03e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—atherosclerosis	1.35e-06	2.01e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—atherosclerosis	8.93e-07	1.33e-05	CbGpPWpGaD
